This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Wista Laboratories Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations by Elizabeth Anne Goatman
Introduction
Elizabeth Anne Goatman is a notable inventor based in Aberdeen, GB. She has made significant contributions to the field of cognitive health through her innovative research and development. Her work primarily focuses on the treatment of Mild Cognitive Impairment (MCI), a condition that affects many individuals worldwide.
Latest Patents
Elizabeth holds a patent for "Phenothiazine compounds for treating mild cognitive impairment." This invention relates to methods and materials based on diaminophenothiazines, which are utilized in the treatment of MCI. Her patent represents a crucial advancement in addressing cognitive health issues.
Career Highlights
Throughout her career, Elizabeth has demonstrated a commitment to improving cognitive health through her research. She is associated with Wista Laboratories Ltd., where she continues to explore innovative solutions for cognitive impairments. Her dedication to her work has positioned her as a key figure in her field.
Collaborations
Elizabeth has collaborated with notable colleagues, including Claude Michel Wischik and Dominic Venay Harbaran. These partnerships have enhanced her research efforts and contributed to the development of effective treatments for cognitive health.
Conclusion
Elizabeth Anne Goatman's contributions to the field of cognitive health through her innovative patent and collaborations highlight her importance as an inventor. Her work continues to pave the way for advancements in treating Mild Cognitive Impairment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile